Reference
Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, González-Grande R, Pizarro A, Durán JA, Jiménez M. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology, 2005; 129(2):512–21.
Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol, 2012; 56(2):374–80.
Carrascosa MF, Salcines-Caviedes JR, Lucena MI, Andrade RJ. Acute liver failure following atorvastatin dose escalation: is there a threshold dose for idiosyncratic hepatotoxicity? J Hepatol, 2014; 62(3):751–52; doi:10.1016/j.jhep.2014.11.019
Chen M, Suzuki A, Borlak J, Andrade RJ, Lucena MI. Drug-induced liver injury: interactions between drug properties and host factors. J Hepatol, 2015; 63(2):503–14; doi:10.1016/j.jhep.2015.04.016
García-Cortés M, Stephens C, Lucena MI, Fernández- Castañer A, Andrade RJ. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol, 2011; 55(3):683–91.
Lammert C, Einarsson S, Saha C, Niklasson A, Bjornsson E, Chalasani N. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology, 2008; 47(6):2003–9.
Perdices EV, Medina-Cáliz I, Hernando S, Ortega A, Martín- Ocaña F, Navarro JM, Peláez G, Castiella A, Hallal H, Romero-Gómez M, González-Jiménez A. Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish hepatotoxicity registry [Hepatotoxicidad Asociada Al Consumo de Estatinas: Análisis de Los Casos Incluidos En El Registro Español de Hepatotoxicidad]. Rev Esp Enferm Dig, 2014; 106(4):246–54.
Robles-Diaz M, Lucena MI, Kaplowitz N, Stephens C, Medina- Cáliz I, González-Jimenez A, Ulzurrun E, Gonzalez AF, Fernandez MC, Romero–Gómez M, Jimenez–Perez M. Use of Hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Gastroenterology, 2014; 147(1):109–118.e5; doi:10.1053/j. gastro.2014.03.050.
Thotakura S, Singh A, Khera K, Chauhan S, Devasia T. Atorvastatin-induced hepatotoxicity, increased by clopidogrel stress on CYP450 enzyme: understanding the mechanism through a case. J Appl Pharm Sci, 2018; 8(4):168–70.
